Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    "methodist hospital" | Open Studies | "Delayed Graft Function" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
Condition: Delayed Graft Function
Interventions: Drug: QPI-1002;   Other: Placebo
2 Recruiting Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant
Condition: Delayed Function of Renal Transplant
Interventions: Drug: SANGUINATE;   Drug: Normal Saline

Indicates status has not been verified in more than two years